Word

TPU PHARMA

Status

Dead

Status Code

606

Status Date

Monday, December 7, 2020

Serial Number

87335893

Mark Type

4000

Filing Date

Tuesday, February 14, 2017

Published for Opposition

Tuesday, September 5, 2017

Abandoned Date

Monday, December 7, 2020

Trademark Owner History

Teikoku Pharma USA, Inc. - Owner At Publication

Classifications

3 Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; non-medicated soaps for personal use; perfumery; essential oils; hair lotions

5 Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical products, namely, analgesics

35 Wholesale and retail store services and online wholesale and retail store services featuring pharmaceutical products and medical devices for storage, application and disposal of pharmaceutical preparations; Retail and wholesale store services and online retail and wholesale store services featuring pharmaceutical preparations, veterinary preparations, sanitary preparations, and medical supplies for storage, application and disposable of pharmaceutical preparations

42 Pharmaceutical research and development; pharmaceutical product evaluation, testing and inspection services; providing medical and scientific research information in the field of pharmaceuticals; information, advisory and consultancy services relating to pharmaceutical product evaluation, testing and inspection services

"PHARMA"
TEIKOKU PHARMA USA PHARMACEUTICAL

Trademark Events

Dec 7, 2020

Abandonment Notice E-Mailed - No Use Statement Filed

Dec 7, 2020

Abandonment - No Use Statement Filed

May 12, 2020

Notice Of Approval Of Extension Request E-Mailed

May 11, 2020

Extension 5 Granted

Apr 24, 2020

Extension 5 Filed

May 11, 2020

Case Assigned To Intent To Use Paralegal

Apr 24, 2020

Teas Extension Received

Oct 30, 2019

Notice Of Approval Of Extension Request E-Mailed

Oct 28, 2019

Extension 4 Granted

Oct 28, 2019

Extension 4 Filed

Oct 28, 2019

Teas Extension Received

Apr 30, 2019

Notice Of Approval Of Extension Request E-Mailed

Apr 26, 2019

Extension 3 Granted

Apr 26, 2019

Extension 3 Filed

Apr 26, 2019

Teas Extension Received

Oct 27, 2018

Notice Of Approval Of Extension Request E-Mailed

Oct 25, 2018

Extension 2 Granted

Oct 25, 2018

Extension 2 Filed

Oct 25, 2018

Teas Extension Received

Apr 24, 2018

Notice Of Approval Of Extension Request E-Mailed

Apr 20, 2018

Extension 1 Granted

Apr 20, 2018

Extension 1 Filed

Apr 20, 2018

Teas Extension Received

Oct 31, 2017

Noa E-Mailed - Sou Required From Applicant

Sep 5, 2017

Official Gazette Publication Confirmation E-Mailed

Sep 5, 2017

Published For Opposition

Aug 16, 2017

Notification Of Notice Of Publication E-Mailed

Jul 26, 2017

Approved For Pub - Principal Register

Jul 26, 2017

Examiner's Amendment Entered

Jul 26, 2017

Notification Of Examiners Amendment E-Mailed

Jul 26, 2017

Examiners Amendment E-Mailed

Jul 26, 2017

Examiners Amendment -Written

Jul 20, 2017

Teas/Email Correspondence Entered

Jul 19, 2017

Correspondence Received In Law Office

Jul 19, 2017

Teas Response To Office Action Received

May 24, 2017

Notification Of Non-Final Action E-Mailed

May 24, 2017

Non-Final Action E-Mailed

May 24, 2017

Non-Final Action Written

May 9, 2017

Assigned To Examiner

Feb 22, 2017

Notice Of Pseudo Mark E-Mailed

Feb 21, 2017

New Application Office Supplied Data Entered In Tram

Feb 17, 2017

New Application Entered In Tram